⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3618634 | 0.78 | — | — | |
| SCHEMBL15442452 | 0.78 | TSHR (0.33) | — | |
| SCHEMBL11851476 | 0.73 | — | — | |
| SCHEMBL4662474 | 0.73 | — | — | |
| SCHEMBL22938711 | 0.73 | — | — | |
| SCHEMBL19558772 | 0.73 | — | — | |
| SCHEMBL19528934 | 0.73 | — | — | |
| SCHEMBL27603530 | 0.73 | — | — | |
| SCHEMBL26326831 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL4191015 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100144639-A1 | USE OF INHIBITORS OF THE EGFR-MEDIATED SIGNAL TRANSDUCTION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) / PROSTATIC HYPERTROPHY | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2010-06-10 | — | — | US | claimed |
| US-20070099918-A1 | Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophy | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2007-05-03 | — | — | US | claimed |
| WO-2017063563-A1 | OCTAHYDROCYCLOPENTA[C]PYRROLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE | 四川海思科制药有限公司 | 2017-04-20 | — | — | WO | disclosed |
| EP-3027293-A1 | SEPARATION OF HYDROGEN SULFIDE FROM NATURAL GAS | ExxonMobil Research and Engineering Company (US) | 2016-06-08 | — | — | EP | disclosed |
| WO-2015017240-A1 | SEPARATION OF HYDROGEN SULFIDE FROM NATURAL GAS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-02-05 | — | — | WO | disclosed |
| US-8722694-B2 | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2014-05-13 | — | — | US | disclosed |
| US-20120329778-A1 | BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2012-12-27 | — | — | US | disclosed |
| US-20100069414-A1 | BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2010-03-18 | — | — | US | disclosed |
| WO-2009152027-A1 | 5,7-DIHYDRO-6H-PYRROLO[2,3-D]PYRIMIDIN-6-ONE DERIVATIVES FOR MARK INHIBITION | MERCK & CO., INC. (US) | 2009-12-17 | — | — | WO | disclosed |
| US-20070185091-A1 | Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing Them | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2007-08-09 | — | — | US | disclosed |
| US-7220750-B2 | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2007-05-22 | — | — | US | disclosed |
| US-7189717-B2 | Medicinal compositions promoting bowel movement | EISAI CO., LTD. (JP) | 2007-03-13 | — | — | US | disclosed |
| US-20020169180-A1 | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-11-14 | — | — | US | disclosed |
| EP-0260685-B1 | INTERNAL MOULD RELEASE AGENTS, THEIR USE IN THE PREPARATION OF MOULDED PIECES ACCORDING TO THE POLYISOCYANATE-POLYADDITION PROCESS, AND PROCESS FOR THE PREPARATION OF MOULDED PIECES | BASF Aktiengesellschaft (DE) | 1991-09-04 | — | — | EP | disclosed |
| US-4764537-A | KETIMINE, ALDIMINE, ENAMINE OR CYCLIC SCHIFF BASE, METAL SALT OF CARBOXYLIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 1988-08-16 | — | — | US | disclosed |
| EP-0260685-A1 | Internal mould release agents, their use in the preparation of moulded pieces according to the polyisocyanate-polyaddition process, and process for the preparation of moulded pieces | BASF Aktiengesellschaft (DE) | 1988-03-23 | — | — | EP | disclosed |
| EP-0010256-B1 | PROCESS FOR PREPARING SYMMETRIC 1,3-DISUBSTITUTED UREAS | BASF Aktiengesellschaft (DE) | 1982-12-29 | — | — | EP | disclosed |
| EP-0010256-A2 | Process for preparing symmetric 1,3-disubstituted ureas | BASF Aktiengesellschaft (DE) | 1980-04-30 | — | — | EP | disclosed |